Maruti Suzuki Ratings| Reduce — Q4 reflected revenue profile concerns

By: |
Published: April 30, 2019 1:24:05 AM

Margins likely to remain under pressure; FY20/21e EPS cut 9%; downgraded to ‘Reduce’ with TP revised to `6,501 from `6,814.

We downgrade to ‘REDUCE/SU’ from ‘HOLD/SP’ with TP of `6,501, valuing it at 22x September 2020 core EPS plus cash per share of `1,417. At CMP, the stock trades at PER of 25.4/23.2x FY20/21e EPS.

The 25% Y-o-Y dip in Maruti Suzuki India’s (MSIL’s) Q4FY19 Ebitda reflects our concern of a weakening revenue profile in a subdued demand and competitive environment. Hence, we revise downwards FY20/21e EPS by 9% each. As per our base case, Q4FY19 Ebit margin of 6.8% is an aberration and we estimate it to recover to 10.5% in FY20 and FY21. However, diminishing product excitement can continue to weigh on earnings in a weak demand environment. Hence, we downgrade to Reduce with revised TP of `6,501 (`6,814 earlier). Despite mere 10% FY19-21e EPS CAGR, we retain our target multiple of 22x core EPS acknowledging MSIL’s strong franchise and FCF. Discontinuation of a few of its diesel options (BS VI transition) sans a strong hybrid replacement could further dent volumes and margins.

Second quarter of margin pressure due to inventory clearance

Q4FY19 revenue at `207 bn (up 1% y-o-y) was ~2% above our estimate as realisations improved driven by sharp reduction in incentives (2% q-o-q). However, Ebit at `14.5 bn was 11% below estimate. Ebit margin at 6.8% was 180bps below estimate due to inventory reduction (50bps), ramp-up costs at the Gujarat facility (70bps) and adverse forex impact (60bps). With dealer inventory normalising (25-28 days), we expect margin to improve going forward.
Strong franchise, but dwindling product excitement

MSIL’s market share gains are likely to sustain riding an impregnable franchise and strong FCF & RoE. However, margin is likely to remain under pressure (versus FY17/FY18 levels) due to an unexciting product pipeline (versus recent past), weak urban sales (down 2% y-o-y in FY19), slowing rural growth (8% in H2FY19 versus 13% in H1) and uncertainty due to BS VI transition.

Outlook & valuation: Consolidation phase; downgrade to ‘REDUCE’
We estimate FY19-21 core EPS CAGR of 10.0% versus 28.5% over FY15-18. Given that MSIL’s valuations track margin, a persistent weakness in margin can lead to de-rating. We downgrade to ‘REDUCE/SU’ from ‘HOLD/SP’ with TP of `6,501, valuing it at 22x September 2020 core EPS plus cash per share of `1,417. At CMP, the stock trades at PER of 25.4/23.2x FY20/21e EPS.

Edelweiss

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Switch to Hindi Edition